Guided Feedback in an Online Game Impacts Decision Making

June 22, 2023 updated by: Justin Dainer-Best, Bard College

Understanding Decision Making Using a Text-based Game

The purpose of the study is to evaluate the use of a text-based game as a way to understand decision making and knowledge related to anxiety, stress, and mood states like depression or loneliness. The investigators are interested in identifying whether participants who are given feedback before and during the game will report changes in behavior or depressive symptoms over the course of a one-week period. This is a follow-up to the published study from the researchers.

Study Overview

Study Type

Interventional

Enrollment (Actual)

350

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Annandale-on-Hudson, New York, United States, 12504
        • Bard College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18+ age
  • Eligible to participate in online research
  • Able to read and respond in English

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: No intervention
Experimental: Video
Short video with BA intervention ideas
Video uses BA techniques for approximately 5 minutes
Experimental: Active game
Feedback Twine game
Game provides positive feedback in response to decisions made by participants
Sham Comparator: Neutral game
Neutral Twine game
Game without feedback
Experimental: Video + Active game
Combines Video and Active game
Video uses BA techniques for approximately 5 minutes
Game provides positive feedback in response to decisions made by participants
Active Comparator: Video + Neutral game
Combines Video and Neutral game
Video uses BA techniques for approximately 5 minutes
Game without feedback

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient health questionnaire (PHQ; 8 items)
Time Frame: baseline (T0) - before intervention
The PHQ measures depression; scores range from 0 to 24 with higher scores indicating more depression.
baseline (T0) - before intervention
patient health questionnaire (PHQ; 8 items)
Time Frame: one week following intervention (T1)
The PHQ measures depression; scores range from 0 to 24 with higher scores indicating more depression.
one week following intervention (T1)
Behavior in study-specific game
Time Frame: Completed at baseline (T0)
For participants completing the game (neutral or active), behavior and choices made will be used as data for analyses. Game choices allow participants to decide what next activities they will "do" in the game. Analyses incorporate decision probabilities (which of 2-5 choices are selected) and compare them between conditions. The game is completed at baseline following assessment (and following video) for those assigned this arm only.
Completed at baseline (T0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Generalized Anxiety Disorder 7 (GAD-7)
Time Frame: Baseline (T0) before intervention
7-item measure of generalized anxiety; scores range from 0 to 21 with higher scores indicating more anxiety.
Baseline (T0) before intervention
Generalized Anxiety Disorder 7 (GAD-7)
Time Frame: one-week follow-up (T1)
7-item measure of generalized anxiety; scores range from 0 to 21 with higher scores indicating more anxiety.
one-week follow-up (T1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2022

Primary Completion (Actual)

May 4, 2022

Study Completion (Actual)

May 4, 2022

Study Registration Dates

First Submitted

June 14, 2023

First Submitted That Met QC Criteria

June 22, 2023

First Posted (Actual)

June 29, 2023

Study Record Updates

Last Update Posted (Actual)

June 29, 2023

Last Update Submitted That Met QC Criteria

June 22, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021NOV10-DAI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data and code for analyses have been shared on the Open Science Framework, https://osf.io/

IPD Sharing Time Frame

IPD will be available when the study is submitted for publication, beginning in 2023.

IPD Sharing Access Criteria

Anyone will be able to access de-identified data and code.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depressive Symptoms

Clinical Trials on Video

3
Subscribe